BioAge Labs

BioAge Labs on fru.dev

• Frontier tech

BioAge Labs across fru.dev: timeline

1. 2026-01-21 BioAge Labs: Public offering $115M (Emerging)
2. 2025-12-04 BioAge reports interim Phase 1 data for NLRP3 inhibitor BGE-102 (Emerging)
3. 2024-09-26 BioAge Labs: IPO $198M (Emerging)
4. 2024-09-26 BioAge Labs prices its Nasdaq IPO (Emerging)

Sources

• emerging.fru.dev/companies/bioage-labs